ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentry   
  • J Biotechnol Biomater 2021, Vol 11(6): 6

Application of Biomaterials

Yangchao Chen*
*Corresponding Author : Yangchao Chen, Department of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Email: yangchachen@cuhk.edu.hk

Abstract

Biomaterials must be compatible with the body, and there are often issues of biocompatibility, which must be resolved before a product can be placed on the market and used in a clinical setting. Because of this, biomaterials are usually subjected to the same requirements as those undergone by new drug therapies. All manufacturing companies are also required to ensure traceability of all of their products, so that if a defective product is discovered, others in the same batch may be traced. Biomaterials are additionally utilized any day in dental applications, surgery, and drug delivery. For example, a put together with impregnated pharmaceutical products can be placed into the body, which permits the prolonged roll out of a drug more than an extended period of time. A biomaterial may additionally bean autograft, allograft or xenograft utilized as a transplant material

Top